Ezetimibe Plus Statin: Attractive Bypass to High-Dose Monotherapy
Early initiation of this approach should be considered in patients with challenging lipid disorders who are at increased risk of atherosclerotic cardiovascular disease events, observers say.
Medscape Medical News
source https://www.medscape.com/viewarticle/978172?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/978172?src=rss
Comments
Post a Comment